{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:19:34Z","timestamp":1793643574696,"version":"4.5.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31873104"],"award-info":[{"award-number":["31873104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.biopha.2019.109359","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T05:05:29Z","timestamp":1566968729000},"page":"109359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Assessment of a new arbidol derivative against herpes simplex virus II in human cervical epithelial cells and in BALB\/c mice"],"prefix":"10.1016","volume":"118","author":[{"given":"Nian","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanqiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9267","key":"10.1016\/j.biopha.2019.109359_bib0005","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"Aids"},{"issue":"14","key":"10.1016\/j.biopha.2019.109359_bib0015","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1177\/0956462417727194","article-title":"2017 European guidelines for the management of genital herpes","volume":"28","author":"Patel","year":"2017","journal-title":"Int. J. STD AIDS"},{"issue":"2","key":"10.1016\/j.biopha.2019.109359_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.olq.0000187211.61052.c7","article-title":"Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons","volume":"33","author":"Ramaswamy","year":"2006","journal-title":"Sex. Transm. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/338231","article-title":"Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis","volume":"185","author":"Wald","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2019.109359_bib0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.2006","article-title":"Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition","volume":"15","author":"Zhu","year":"2009","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.biopha.2019.109359_bib0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/513566","article-title":"The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania","volume":"195","author":"Kapiga","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2019.109359_bib0040","doi-asserted-by":"crossref","first-page":"e0140765","DOI":"10.1371\/journal.pone.0140765","article-title":"Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2019.109359_bib0045","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/343739","article-title":"Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review","volume":"186","author":"Smith","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2019.109359_bib0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-981-10-7230-7_6","article-title":"Antiviral drugs against alphaherpesvirus","volume":"1045","author":"Shiraki","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1345\/aph.17135","article-title":"Acyclovir- and ganciclovir-induced neurotoxicity","volume":"32","author":"Ernst","year":"1998","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2019.109359_bib0060","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000188514","article-title":"Avoiding acyclovir neurotoxicity in patients with chronic renal failure undergoing haemodialysis","volume":"69","author":"Almond","year":"1995","journal-title":"Nephron"},{"issue":"12","key":"10.1016\/j.biopha.2019.109359_bib0065","first-page":"Cs75","article-title":"Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children","volume":"11","author":"Khurana","year":"2005","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.biopha.2019.109359_bib0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2019.109359_bib0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1743-422X-3-56","article-title":"Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection","volume":"3","author":"Boriskin","year":"2006","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","article-title":"In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant","volume":"90","author":"Delogu","year":"2011","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109359_bib0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00705-009-0346-4","article-title":"Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo","volume":"154","author":"Zhong","year":"2009","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0090","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1038\/s41598-018-27224-4","article-title":"The antiviral drug arbidol inhibits zika virus","volume":"8","author":"Fink","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2019.109359_bib0095","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2174\/138161209787846847","article-title":"Synthetic and natural immunomodulators acting as interferon inducers","volume":"15","author":"Silin","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.biopha.2019.109359_bib0100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/aps.2013.54","article-title":"Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0105","doi-asserted-by":"crossref","first-page":"e15874","DOI":"10.1371\/journal.pone.0015874","article-title":"Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol","volume":"6","author":"Teissier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2019.109359_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res."},{"issue":"Pt 11","key":"10.1016\/j.biopha.2019.109359_bib0115","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1099\/jmm.0.076612-0","article-title":"In vitro antiviral and immunomodulatory activity of arbidol and structurally related derivatives in herpes simplex virus type 1-infected human keratinocytes (HaCat)","volume":"63","author":"Perfetto","year":"2014","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijantimicag.2017.09.001","article-title":"Antiviral activity of arbidol hydrochloride against herpes simplex virus I in vitro and in vivo","volume":"51","author":"Li","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbrc.2008.12.150","article-title":"HSV-2 induces TLRs and NF-kappaB-dependent cytokines in cervical epithelial cells","volume":"379","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.biopha.2019.109359_bib0130","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1128\/JVI.02243-12","article-title":"Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes","volume":"87","author":"Drannik","year":"2013","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109359_bib0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0166-3542(02)00054-2","article-title":"Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication","volume":"55","author":"Gong","year":"2002","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.109359_bib0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.antiviral.2003.09.006","article-title":"Treatment of herpes simplex virus infections","volume":"61","author":"Brady","year":"2004","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/095632020401500303","article-title":"Helicase primase: targeting the Achilles heel of herpes simplex viruses","volume":"15","author":"Kleymann","year":"2004","journal-title":"Antivir. Chem. Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2006.03.017","article-title":"Experimental study on the action of allitridin against human cytomegalovirus in vitro: inhibitory effects on immediate-early genes","volume":"72","author":"Zhen","year":"2006","journal-title":"Antiviral Res."},{"issue":"13","key":"10.1016\/j.biopha.2019.109359_bib0155","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1128\/JVI.00636-15","article-title":"Dynasore disrupts trafficking of herpes simplex virus proteins","volume":"89","author":"Mues","year":"2015","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/01480540903311050","article-title":"A 4-week oral toxicity study of an antiviral drug combination consisting of arbidol and acetaminophen in rats","volume":"33","author":"Wang","year":"2010","journal-title":"Drug Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2019.109359_bib0165","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00705-007-0974-5","article-title":"Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo","volume":"152","author":"Shi","year":"2007","journal-title":"Arch. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1023\/A:1016499810146","article-title":"Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet","volume":"4","author":"Reefschlager","year":"1987","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.109359_bib0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-3542(01)00207-8","article-title":"Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein","volume":"53","author":"Yao","year":"2002","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.biopha.2019.109359_bib0180","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1128\/JVI.02854-15","article-title":"ICP8 filament formation is essential for replication compartment formation during herpes simplex virus infection","volume":"90","author":"Darwish","year":"2015","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.biopha.2019.109359_bib0185","doi-asserted-by":"crossref","first-page":"13582","DOI":"10.1128\/JVI.78.24.13582-13590.2004","article-title":"Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway","volume":"78","author":"Gregory","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109359_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2008.10.005","article-title":"Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women","volume":"81","author":"Nazli","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.biopha.2019.109359_bib0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molimm.2016.12.021","article-title":"Maspin inhibits macrophage phagocytosis and enhances inflammatory cytokine production via activation of NF-kappaB signaling","volume":"82","author":"Wang","year":"2017","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109359_bib0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jviromet.2013.02.006","article-title":"An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2","volume":"189","author":"Yin","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.biopha.2019.109359_bib0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.micpath.2017.12.017","article-title":"Anti HSV-2 activity of Peganum harmala (L.) and isolation of the active compound","volume":"114","author":"Benzekri","year":"2018","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12906-017-1620-8","article-title":"Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids","volume":"17","author":"Kesharwani","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2019.109359_bib0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.intimp.2018.09.043","article-title":"The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis","volume":"68","author":"Du","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2000.0529","article-title":"Three classes of cell surface receptors for alphaherpesvirus entry","volume":"275","author":"Spear","year":"2000","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.biopha.2019.109359_bib0225","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2217\/fvl.15.85","article-title":"Cell entry mechanisms of HSV: what we have learned in recent years","volume":"10","author":"Agelidis","year":"2015","journal-title":"Future Virol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109359_bib0230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1462-5822.2004.00389.x","article-title":"Herpes simplex virus: receptors and ligands for cell entry","volume":"6","author":"Spear","year":"2004","journal-title":"Cell. Microbiol."},{"issue":"24","key":"10.1016\/j.biopha.2019.109359_bib0235","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1111\/j.1742-4658.2009.07402.x","article-title":"Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry","volume":"276","author":"Akhtar","year":"2009","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/tra.12340","article-title":"HSV-1 glycoproteins are delivered to virus assembly sites through dynamin-dependent endocytosis","volume":"17","author":"Albecka","year":"2016","journal-title":"Traffic"},{"issue":"9","key":"10.1016\/j.biopha.2019.109359_bib0245","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00705-015-2514-z","article-title":"Antiherpes evaluation of soybean isoflavonoids","volume":"160","author":"Argenta","year":"2015","journal-title":"Arch. Virol."},{"issue":"20","key":"10.1016\/j.biopha.2019.109359_bib0250","doi-asserted-by":"crossref","first-page":"9943","DOI":"10.1128\/JVI.01036-06","article-title":"Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production","volume":"80","author":"Gill","year":"2006","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.biopha.2019.109359_bib0255","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States","volume":"296","author":"Xu","year":"2006","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.biopha.2019.109359_bib0260","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bpobgyn.2014.07.015","article-title":"Genital herpes","volume":"28","author":"Garland","year":"2014","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbf.1810","article-title":"Protective effect of brown Brazilian propolis against acute vaginal lesions caused by herpes simplex virus type 2 in mice: involvement of antioxidant and anti-inflammatory mechanisms","volume":"30","author":"Sartori","year":"2012","journal-title":"Cell Biochem. Funct."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13365-014-0302-2","article-title":"Animal models of herpes simplex virus immunity and pathogenesis","volume":"21","author":"Kollias","year":"2015","journal-title":"J. Neurovirol."},{"issue":"9","key":"10.1016\/j.biopha.2019.109359_bib0275","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/jid.2013.150","article-title":"Mast cells play a key role in host defense against herpes simplex virus infection through TNF-alpha and IL-6 production","volume":"133","author":"Aoki","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0280","first-page":"737","article-title":"Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation","volume":"43","author":"Fenton","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0285","first-page":"220","article-title":"TNF inhibitors for rheumatoid arthritis - a year in review","volume":"69","author":"Simsek","year":"2011","journal-title":"Bull. NYU Hosp. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0290","first-page":"31","article-title":"Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling","volume":"4","author":"Carmody","year":"2007","journal-title":"Cell. Mol. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2019.109359_bib0295","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2019.109359_bib0300","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/vim.2005.18.457","article-title":"Herpes simplex virus and toll-like receptors","volume":"18","author":"Finberg","year":"2005","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109359_bib0305","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy","volume":"16","author":"Bacon","year":"2003","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219320001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219320001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:16:10Z","timestamp":1776428170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219320001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":61,"alternative-id":["S0753332219320001"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109359","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of a new arbidol derivative against herpes simplex virus II in human cervical epithelial cells and in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109359"}}